CASP5 and infection: WT THP-1s treated with either CASP4 or CASP5 siRNAs exhibited significantly decreased IL-1β secretion following WT Stm infection relative to WT THP-1s treated with control siRNA (Fig 4A, 4B, 4D and 4E), in agreement with our previous observations in primary human macrophages [69].